ALT A graph showing monthly hereditary angioedema attack rate over time. "Weeks since Infusion" is on the x-axis, while "Mean No. of Attacks per Month" is on the y-axis. The table below shows the number of participants at risk in each group at different time points.

ALT A graph showing the change from baseline in total plasma kallikrein protein levels. "Weeks since Infusion" is on the x-axis, while "Mean Percent Change" is on the y-axis. The table below shows the number of participants at risk in each group at different time points.

ALT The years above the horizontal line indicate FDA-approval for obesity treatment, while those below show approval for obesity-related conditions for the same active ingredient (doses and administration forms can differ), with consistent colour coding for each agent across indications. FDA=US Food and Drug Administration. MASLD=metabolic dysfunction-associated steatotic liver disease. OSAS=obstructive sleep apnoea syndrome. sc=subcutaneous.

ALT This image is a detailed infographic on standard-of-care testing and long-read genome sequencing as first-tier approaches to genetic testing. It includes an assessment of diagnostic samples, diagnostic yield, concordance according to variant type, and diagnostic yield.